JP2018513117A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513117A5 JP2018513117A5 JP2017546870A JP2017546870A JP2018513117A5 JP 2018513117 A5 JP2018513117 A5 JP 2018513117A5 JP 2017546870 A JP2017546870 A JP 2017546870A JP 2017546870 A JP2017546870 A JP 2017546870A JP 2018513117 A5 JP2018513117 A5 JP 2018513117A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- formulated
- dexamethasone
- corneal
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ70572715 | 2015-03-05 | ||
| NZ705727 | 2015-03-05 | ||
| PCT/NZ2016/050033 WO2016140581A1 (en) | 2015-03-05 | 2016-03-04 | Ophthalmic compositions and methods of use therefor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021011148A Division JP2021091688A (ja) | 2015-03-05 | 2021-01-27 | 眼科用組成物およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018513117A JP2018513117A (ja) | 2018-05-24 |
| JP2018513117A5 true JP2018513117A5 (https=) | 2019-04-11 |
Family
ID=56848288
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017546870A Pending JP2018513117A (ja) | 2015-03-05 | 2016-03-04 | 眼科用組成物およびその使用方法 |
| JP2021011148A Pending JP2021091688A (ja) | 2015-03-05 | 2021-01-27 | 眼科用組成物およびその使用方法 |
| JP2023030945A Active JP7641650B2 (ja) | 2015-03-05 | 2023-03-01 | 眼科用組成物およびその使用方法 |
| JP2024218517A Pending JP2025032318A (ja) | 2015-03-05 | 2024-12-13 | 眼科用組成物およびその使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021011148A Pending JP2021091688A (ja) | 2015-03-05 | 2021-01-27 | 眼科用組成物およびその使用方法 |
| JP2023030945A Active JP7641650B2 (ja) | 2015-03-05 | 2023-03-01 | 眼科用組成物およびその使用方法 |
| JP2024218517A Pending JP2025032318A (ja) | 2015-03-05 | 2024-12-13 | 眼科用組成物およびその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10842850B2 (https=) |
| EP (1) | EP3265096B9 (https=) |
| JP (4) | JP2018513117A (https=) |
| KR (1) | KR102450674B1 (https=) |
| CN (1) | CN107530360B (https=) |
| AU (1) | AU2016226699B2 (https=) |
| ES (1) | ES2952700T3 (https=) |
| MY (1) | MY186271A (https=) |
| SG (1) | SG11201708114SA (https=) |
| TW (1) | TWI747816B (https=) |
| WO (1) | WO2016140581A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
| EP4420725A3 (en) | 2012-03-29 | 2025-04-16 | Epion Therapeutics, Inc. | Ocular treatment solutions, delivery devices and delivery augmentation methods |
| WO2013149075A1 (en) | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Compositions and methods for treating or preventing diseases associated with oxidative stress |
| EP3265096B9 (en) | 2015-03-05 | 2023-10-04 | TheiaNova Limited | Ophthalmic compositions and methods of use therefor |
| US11207410B2 (en) | 2015-07-21 | 2021-12-28 | Avedro, Inc. | Systems and methods for treatments of an eye with a photosensitizer |
| CN110092816B (zh) * | 2018-01-29 | 2023-08-01 | 上海市第一人民医院 | 预防和治疗纤维化的小分子多肽及其应用 |
| US20210060017A1 (en) * | 2018-02-27 | 2021-03-04 | Shilpa Medicare Ltd | Methotrexate ophthalmic solution |
| CN108728418A (zh) * | 2018-06-19 | 2018-11-02 | 新乡医学院 | 一种鸡胚中枢神经系统单个神经元动态研究模型的制备方法及应用 |
| JP7394850B2 (ja) * | 2018-11-02 | 2023-12-08 | センセオニクス，インコーポレーテッド | 分析物指示薬上の薬剤溶出マトリクス |
| GB201820021D0 (en) * | 2018-12-07 | 2019-01-23 | Univ Birmingham | Ocular hydrogel compositions |
| JP2022125941A (ja) * | 2021-02-17 | 2022-08-29 | 株式会社ティ・エム・ディ | コンタクトレンズ |
| EP4580600A1 (en) | 2022-09-01 | 2025-07-09 | Optifye Therapeutics AG | Ophthalmic compositions |
| WO2024206871A1 (en) * | 2023-03-30 | 2024-10-03 | Cetel Scientific Llc | Amniotic and chorionic collagen for ocular surface healing |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3786812A (en) * | 1972-03-10 | 1974-01-22 | C Neefe | Contact lens for olar drug delivery |
| US4177268A (en) | 1973-05-30 | 1979-12-04 | Jouveinal S.A. | Method of alleviating inflammation by administration of dexamethasone derivatives |
| US5124392A (en) * | 1988-10-03 | 1992-06-23 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation |
| DE69132275T2 (de) * | 1990-11-16 | 2001-01-25 | Celtrix Pharmaceuticals, Inc. | Beta-type ähnlicher transformierender wachstumfaktor |
| US5411940A (en) | 1993-09-29 | 1995-05-02 | Alcon Laboratories, Inc. | Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma |
| WO2004071283A2 (en) | 2003-02-13 | 2004-08-26 | Anthrogenesis Corporation | Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
| MXPA03011987A (es) | 2003-12-19 | 2005-06-23 | Osio Sancho Alberto | Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal. |
| WO2007099337A1 (en) | 2006-03-01 | 2007-09-07 | Cartela R&D Ab | Expansion and differentiation of mesenchymal stem cells |
| GB0604938D0 (en) | 2006-03-11 | 2006-04-19 | Renovo Ltd | Proteins, nucleic acids and medicaments |
| US7767217B2 (en) | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
| WO2008067158A2 (en) | 2006-11-13 | 2008-06-05 | Auxagen, Inc. | METHOD TO PROMOTE HAIR GROWTH AND/OR DELAY OR TREAT HAIR LOSS BY ADMINISTERING A TGF-β ANTAGONIST OR INHIBITOR |
| EP2091557A2 (en) | 2006-11-15 | 2009-08-26 | Coda Therapeutics, INC. | Improved methods and compositions for wound healing |
| JP2011505409A (ja) | 2007-12-04 | 2011-02-24 | ノバガリ ファーマ エスエー | パルミチン酸デキサメタゾンのようなコルチコステロイドプロドラッグを含有する眼障害の治療用の組成物 |
| US7795316B1 (en) | 2007-12-19 | 2010-09-14 | Alcon Research, Ltd. | Topical ophthalmic compositions containing tobramycin and dexamethasone |
| CN101970042A (zh) | 2008-02-25 | 2011-02-09 | 眼门药品公司 | 经由离子电渗法增强递送治疗药物至眼部组织 |
| EP2370054B1 (en) * | 2008-12-11 | 2015-10-07 | Massachusetts Institute of Technology | Contact lens drug delivery device |
| US10201548B2 (en) | 2009-03-06 | 2019-02-12 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| WO2012088044A2 (en) | 2010-12-20 | 2012-06-28 | James Mcmillan | Compositions and methods for improving ocular surface health, corneal clarity, optical function and maintaining visual acuity |
| US20130165419A1 (en) | 2011-12-21 | 2013-06-27 | Insite Vision Incorporated | Combination anti-inflammatory ophthalmic compositions |
| KR101518370B1 (ko) | 2013-06-25 | 2015-05-07 | 가톨릭대학교 산학협력단 | Il-10 생성 조절 t세포로의 분화 유도용 조성물 |
| CN104548210A (zh) | 2014-12-13 | 2015-04-29 | 浙江大学 | 含地塞米松转化生长因子的可控缓释plga微球及制备 |
| EP3265096B9 (en) | 2015-03-05 | 2023-10-04 | TheiaNova Limited | Ophthalmic compositions and methods of use therefor |
| US10537585B2 (en) | 2017-12-18 | 2020-01-21 | Dexcel Pharma Technologies Ltd. | Compositions comprising dexamethasone |
-
2016
- 2016-03-04 EP EP16759200.5A patent/EP3265096B9/en active Active
- 2016-03-04 MY MYPI2017703238A patent/MY186271A/en unknown
- 2016-03-04 CN CN201680026065.0A patent/CN107530360B/zh active Active
- 2016-03-04 TW TW105106605A patent/TWI747816B/zh active
- 2016-03-04 WO PCT/NZ2016/050033 patent/WO2016140581A1/en not_active Ceased
- 2016-03-04 ES ES16759200T patent/ES2952700T3/es active Active
- 2016-03-04 AU AU2016226699A patent/AU2016226699B2/en active Active
- 2016-03-04 JP JP2017546870A patent/JP2018513117A/ja active Pending
- 2016-03-04 KR KR1020177028161A patent/KR102450674B1/ko active Active
- 2016-03-04 US US15/555,909 patent/US10842850B2/en active Active
- 2016-03-04 SG SG11201708114SA patent/SG11201708114SA/en unknown
-
2020
- 2020-10-23 US US17/078,949 patent/US11938168B2/en active Active
-
2021
- 2021-01-27 JP JP2021011148A patent/JP2021091688A/ja active Pending
-
2023
- 2023-03-01 JP JP2023030945A patent/JP7641650B2/ja active Active
-
2024
- 2024-12-13 JP JP2024218517A patent/JP2025032318A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018513117A5 (https=) | ||
| Kim et al. | Laser in situ keratomileusis versus laser-assisted subepithelial keratectomy for the correction of high myopia | |
| Miranda et al. | Ferrara intrastromal corneal ring segments for severe keratoconus | |
| Coscarelli et al. | Intrastromal corneal ring segment implantation to correct astigmatism after penetrating keratoplasty | |
| Zhang et al. | A review of collagen cross‐linking in cornea and sclera | |
| Pellegrini et al. | Outcomes of cataract surgery with toric intraocular lens implantation after keratoplasty | |
| Paysse et al. | Pediatric refractive surgery: corneal and intraocular techniques and beyond | |
| Althomali | Posterior chamber toric phakic IOL implantation for the management of pediatric anisometropic amblyopia | |
| Kramer et al. | Scleral lenses in the treatment of post-LASIK ectasia and superficial neovascularization of intrastromal corneal ring segments | |
| El-Agha et al. | Comparison of photorefractive keratectomy and laser in situ keratomileusis for the treatment of compound hyperopic astigmatism | |
| Manns et al. | Use of corneal cross-linking beyond keratoconus: a systemic literature review | |
| Eissa et al. | ICL versus SMILE in management of anisometropic myopic amblyopia in children | |
| Kim et al. | Full-thickness astigmatic keratotomy combined with small-incision lenticule extraction to treat high-level and mixed astigmatism | |
| Durrie et al. | Secondary intraocular lens implantation vs epikeratophakia for the treatment of aphakia | |
| Hafez | Comparison of epithelium-off and transepithelial corneal collagen cross-linking for treatment of keratoconus | |
| Chen et al. | Management of complex epithelial ingrowth after laser in situ keratomileusis using fibrin tissue glue | |
| Magli et al. | Photorefractive keratectomy for myopic anisometropia: a retrospective study on 18 children | |
| Schornack | Medical indications for scleral lens use | |
| Jankov et al. | Lenticular intrastromal keratoplasty for keratoconus | |
| RU2816066C1 (ru) | Способ лечения повреждений роговичного лоскута микрокератомом в процессе кераторефракционной операции LASIK или Femtolasik | |
| Sánchez-González et al. | Permavision intracorneal inlay after sixteen years. Regression of initial refractive hyperopia | |
| Shuber | Implantable Collamer Lens for correction of refractive errors in patients with keratoconus following collagen cross-linking: one year follow-up | |
| Artemiev | Effect of postoperative subconjunctival corticosteroid injections in a multimodal approach for the treatment of severe symblepharon | |
| Bakhsh et al. | Combined corneal wavefront-guided transepithelial photorefractive keratectomy and accelerated corneal collagen cross-linking following intracorneal ring segment implantation in management of moderate keratoconus | |
| Soori et al. | Refractive outcomes of small incision lenticule extraction with accelerated cross-linking (ReLEx SMILE Xtra) in patients with thin cornea |